Apellis

formerly Apellis PharmaceuticalsAcquired

Courageous Science + Compassion

Apellis is a biotech company in Waltham, United States, founded in 2009. It has raised $522.6M across 5 rounds, most recently a $350.0M Corporate Round in February 2023.

Employees
501–1000
Founded
2009
Business Model
B2B
Total Funding
$522.6M
Last Round
$350.0M Corporate RoundFeb 2023
Rounds
5
Type
Public
Acquisition Date
Jun 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 12 investors for this company. to use credits for reveals, or explore the API.

About

Apellis Pharmaceuticals (Nasdaq: APLS) is a clinical-stage and commercial-stage biopharmaceutical company focused on the complement system, a key branch of innate immunity. Founded in 2009 by Cedric Francois and Dinesh Bhatt, the company pioneered targeted C3 inhibition with its lead compound pegcetacoplan. Apellis received FDA approval for EMPAVELI for paroxysmal nocturnal hemoglobinuria (PNH) in 2021 and SYFOVRE for geographic atrophy (GA) in 2023 — the first approved treatment for GA. Headquartered in Waltham, Massachusetts.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionJun 2026

9 more events

  • Acquisition20251 investor
  • Debt Financing20241 investor
  • Corporate Round20231 investor

Funding: Venture Round through Corporate Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Backend ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Apellis on Indexed.vc
<a href="https://indexed.vc/companies/apellis"><img src="https://indexed.vc/api/badge/company/apellis" alt="Apellis on Indexed.vc" width="260" height="76" /></a>